...
首页> 外文期刊>Cell death & disease. >Familial amyloid precursor protein mutants cause caspase-6-dependent but amyloid β-peptide-independent neuronal degeneration in primary human neuron cultures.
【24h】

Familial amyloid precursor protein mutants cause caspase-6-dependent but amyloid β-peptide-independent neuronal degeneration in primary human neuron cultures.

机译:家族性淀粉样前体蛋白突变体在人类原代神经元培养物中引起caspase-6依赖性但淀粉样β肽依赖性神经元变性。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Although familial Alzheimer disease (AD)-associated autosomal dominant mutants have been extensively studied, little is known about the underlying molecular mechanisms of neurodegeneration induced by these mutants in AD. Wild-type, Swedish or London amyloid precursor protein (APP) transfection in primary human neurons induced neuritic beading, in which several co-expressed proteins, such as enhanced green fluorescent protein, red fluorescent protein (RFP)-tau and RFP-ubiquitin, accumulated. APP-induced neuritic beading was dependent on caspase-6 (Casp6), because it was inhibited with 5?μM z-VEID-fmk or with dominant-negative Casp6. Neuritic beading was independent from APP-mediated amyloid β-peptide (Aβ) production, because the APPM596V (APPMV) mutant, which cannot generate Aβ, still induced Casp6-dependent neuritic beading. However, the beaded neurons underwent Casp6- and Aβ-dependent cell death. These results indicate that overexpression of wild-type or mutant APP causes Casp6-dependent but Aβ-independent neuritic degeneration in human neurons. Because Casp6 is activated early in AD and is involved in axonal degeneration, these results suggest that the inhibition of Casp6 may represent an efficient early intervention against familial forms of AD. Furthermore, these results indicate that removing Aβ without inhibiting Casp6 may have little effect in preventing the progressive dementia associated with sporadic or familial AD.. ? 2010 Macmillan Publishers Limited
机译:尽管家族性阿尔茨海默病(AD)相关的常染色体显性突变体已得到广泛研究,但对于这些突变体在AD中引起的神经退行性变的潜在分子机制知之甚少。原代人神经元中的野生型,瑞典或伦敦淀粉样前体蛋白(APP)转染诱导了神经串珠,其中几种共表达的蛋白,例如增强的绿色荧光蛋白,红色荧光蛋白(RFP)-tau和RFP-泛素,积累。 APP诱导的神经串珠取决于caspase-6(Casp6),因为它被5?μMz-VEID-fmk或显性负性Casp6抑制。神经性串珠独立于APP介导的淀粉样β肽(Aβ)的产生,因为不能产生Aβ的APPM596V(APP MV )突变体仍诱导Casp6依赖性神经串珠。然而,珠状神经元经历了Casp6-和Aβ依赖性细胞死亡。这些结果表明,野生型或突变型APP的过表达引起人神经元中Casp6依赖性但Aβ依赖性的神经变性。因为Casp6在AD早期被激活并参与轴突变性,所以这些结果表明Casp6的抑制可能代表了针对家族形式AD的有效早期干预。此外,这些结果表明,在不抑制Casp6的情况下去除Aβ对预防与散发性或家族性AD相关的进行性痴呆的作用很小。 2010 Macmillan Publishers Limited

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号